Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line

Bioscience, Biotechnology and Biochemistry

Volumn 67, Issue 11, 2003, Pages 2344-2350

  Song, Joon Seok ^a   Kim, Hyun Pyo ^b   Yoon, Won Suck ^a   Lee, Kyu Wan ^c   Kim, Mee Hye ^d   Kim, Kyung Tai ^e   Kim, Hy Sook ^f   Kim, Young Tae ^c  

^a Korea University   (South Korea)

^b R and D Center   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Sewha Pediatric Clinic   (South Korea)

^e Hanyang University   (South Korea)

^f Sungkyunkwan University   (South Korea)

Author keywords

Adenovirus; HSV TK; hTERT promoter; Targeted cancer gene therapy; Telomerase

Indexed keywords

ADENOVIRIDAE; CUCUMBER MOSAIC VIRUS;

DNA BINDING PROTEIN; LUCIFERASE; PROTEIN SUBUNIT; TELOMERASE;

ADENOVIRUS; APOPTOSIS; ARTICLE; CELL LINE; ENZYMOLOGY; FEMALE; FIBROBLAST; GENE THERAPY; GENETICS; HUMAN; METHODOLOGY; MOLECULAR CLONING; OVARY TUMOR; PLASMID; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ADENOVIRIDAE; APOPTOSIS; CELL LINE; CELL LINE, TUMOR; CLONING, MOLECULAR; DNA-BINDING PROTEINS; FEMALE; FIBROBLASTS; GENE THERAPY; GENES, REPORTER; HUMANS; LUCIFERASES; OVARIAN NEOPLASMS; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEIN SUBUNITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE;

EID: 3242878021     PISSN: 09168451     EISSN: None     Source Type: Journal    
DOI: 10.1271/bbb.67.2344     Document Type: Article

References (24)

1. Auersperg, N., Maines-Bandiera, S., Booth, J. H., Lynch, H. T., Godwin, A. K., and Hamilton, T. C., Expression of two mucin antigens in cultured human ovarian surface epithelium: influence of a family history of ovarian cancer. Am. J. Obstet. Gynecol., 173, 558-565 (1995).
2. Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazddar, F. G., Piatyszek, M. A., and Shay, J. W., Telomerase activity in small-cell and non-small-cell lung cancer. J. Natl. Cancer Inst., 87, 895-901 (1995).
3. Chadeneau, C., Hay, K., Hirte, H. W., Gallinger, S., and Bacchetti, S., Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res., 55, 2533-2536 (1995).
4. Sahara, H., Nakanishi, T., Kitamoto, M., Nakashio, R., Shay, J. W., Tahara, E., Kajiyama, G., and Ide, T., Telomerase activity in human liver tissue: Comparison between chronic liver disease and hepatocellular carcinoma. Cancer Res., 55, 2734-2736 (1995).
5. Counter, C. M., Guota, J., Harley, C. B., Leber, B., and Bacchetti, S., Telomerase activity in normal leukocytes and in hematologic malignancies. Blood, 85, 2315-2320 (1995).
6. Schwartz, H. S., Juliao, S. F., Sciadini, M. F., Miller, L. K., and Butler, M. G., Telomerase activity and oncogenesis in giant cell tumor of bone. Cancer, 75, 1094-1099 (1995).
7. Sommerfeld, H. J., Meeker, A. K., Piatyszek, M. A., Bova, G. S., and Coffey, D. S., Telomerase activity: A prevalent marker of malignant human prostate tissue. Cancer Res., 56, 218-222 (1996).
8. Hiyama, E., Gollahon, L., Kataoka, T., Kuroi, K., Yokoyama, T., Gazdar, A. F., Hiyama, K., Piatyszek, M. A., and Shay, J. W., Telomerase activity in human breast tumors. J. Natl. Cancer Inst., 88, 116-122 (1996).
9. Counter, C. M., Irte, H. W., Bacchtti, S., and Harley, C. B., Telomerase activity in human ovarian carcinoma. Proc. Natl. Acad. Sci. USA, 91, 2900-2904 (1994).
10. Feng, J., Funk, W. D., Wang, S. S., Weinric, A. A. A., Ciu, C. P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrew, W. H., Greider, C. W., and Villeponteau, B., The RNA component of human telomerase. Science, 269, 1236-1241 (1995).
11. Ito, H., Kyo, S., Kanaya, T., Takakura, M., Inoue, M., and Namiki, M., Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin. Cancer Res., 4, 1603-1608 (1998).
12. Kanaya, T., Kyo, S., Takakura, M., Ito, H., Namiki, M., and Inoue, M., hTERT is a critical determinant of telomerase activity in renal carcinoma. Int. J. Cancer, 78, 539-543 (1998).
13. Takakura, M., Kyo, S., Kanaya, T., Tanaka, M., and Inoue, M., Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res., 58, 1558-1561 (1998).
14. Izumi, H. P., Louann, C., Cynthia, A., and Carl, B., Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res., 59, 826-830 (1999).
15. Masahiro, T., Satoru, K., Taro, K., Hisao, H., Jun, T., Masuo, Y., and Masaki, I., Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res., 59, 551-557 (1999).
16. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinric, S. L., and Shay, J. W., Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011-2015 (1994).
17. Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., and Cech, T. R., Telomerase catalytic subunit homologs from fission yeast and human. Science, 277, 955-959 (1997).
18. Becker, T. C., Noel, R. J., Coats, W. S., et al., Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol., 43, 161-189 (1994).
19. Graham, F. L., and Van Der Eb, A. J., A new technique for the assay of infectivity of human adenovirus 5 DNA. Viology, 52, 456-467 (1973).
20. Komata, T., Kanzawa, T., Kondo, Y., and Kondo, S., Telomerase as a therapeutic target for malignant gliomas. Oncogene, 21, 656-663 (2002).
21. Song, J. S., Kim, S. B., Lee, K. W., Jung, H. H., Kim, M. H., Kim, K. T., Brown, R., and Kim, Y. T., Adenovirus-mediated antisense expression of telomerase template RNA induces apoptosis in lung cancer cells. J. Microbiol. Biotechnol., 12, 89-95 (2002).
22. Song, J. S., Kim, D. S., Lee, K. W., Kim, M. H., Kim, K. T., and Kim, Y. T., Adenovirus-mediated antisense telomerase with cisplatin increased susceptibility to cisplatin resistant ovarian cancer cell line. J. Microbiol. Biotechnol., 12, 711-715 (2002).
23. Kou-Juey, Wu, Carla, G., Mario, A., Natalie, S., Axel, P., Joachim, L., and Riccardo, D. F., Direct activation of TERT transcription by c-Myc. Nature Genetics, 21, 220-224 (1999).
24. Kohtaro, F., and Morinobu, T., Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-Myc mRNA. Biochem. Biophys. Res. Commun., 248, 368-371 (1997).